New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
RenovoRx, Inc.
RNXT
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

24M

Biotechnology

Next Earning date - 11 Nov 2024

24M

Biotechnology

Next Earning date - 11 Nov 2024

1.00USD
0.00 ( 0.00%)
favorite-chart

Relative Strenght

15
favorite-chart

Volume Buzz

-70%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

57%

Quote Panel

Shape
Updated October 19, 2024
1W 0.00 % 1M -18.03 % 3M -15.25 % 1Y -13.79 %

Key Metrics

Shape
  • Market Cap

    23.99M


  • Shares Outstanding

    23.99M


  • Share in Float

    23.53M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    1


  • Average Volume

    31962


  • Beta

    0.984


  • Range

    0.531-2.35


  • Industry

    Biotechnology


  • Website

    https://renovorx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

2.67x

P/B Ratio

0.0

Debt/Equity

0.0%

Net Margin

$-0.6

EPS

How RNXT compares to sector?

P/E Ratio

Relative Strength

Shape

RNXT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$28M

ShapeNaN%

2025-Revenue

$0.41

Shape-316%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Ascendiant

initialise

Previous: Not converted

2024-06-17

Now: Buy

Maxim Group

upgrade

Previous: Not converted

2024-02-29

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.24
vs -0.27

Q4.22

arrow
arrow

N/A

-0.23
vs -0.12

Q1.23

arrow
arrow

N/A

-0.36
vs -0.33

Q2.23

arrow
arrow

N/A

-0.22
vs -0.29

Q3.23

arrow
arrow

N/A

-0.27
vs -0.24

Q4.23

arrow
arrow

N/A

-0.31
vs -0.23

Q1.24

arrow
arrow

N/A

-0.07
vs -0.36

Q2.24

arrow
arrow

N/A

-0.10
vs -0.22

Q3.24

arrow
arrow

N/A

-0.12
vs -0.27

Q4.24

arrow
arrow

N/A

-0.10
vs -0.31

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-26%

-0.26
vs -0.25

Q4.22

arrow
arrow

-34%

-0.34
vs -0.26

Q1.23

arrow
arrow

-100%

-1.00
vs -0.34

Q2.23

arrow
arrow

-196%

-1.96
vs -1.00

Q3.23

arrow
arrow

-23683%

-236.83
vs -1.96

Q4.23

arrow
arrow

+108%

1.08
vs -236.83

Q1.24

arrow
arrow

-61%

-0.61
vs 1.08

Q2.24

arrow
arrow

-26%

-0.26
vs -0.61

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

12

12
vs 9

33%

Q4.22

arrow
arrow

11

11
vs 12

-8%

Q1.23

arrow
arrow

12

12
vs 11

9%

Q2.23

arrow
arrow

9

9
vs 12

-25%

Q3.23

arrow
arrow

14

14
vs 9

56%

Q4.23

arrow
arrow

11

11
vs 14

-21%

Q1.24

arrow
arrow

9

9
vs 11

-18%

Q2.24

arrow
arrow

16

16
vs 9

78%

Earnings Growth

Latest News